Global Cystic Fibrosis Drugs Market Insights, Forecast to 2025

Table of Contents

1 Study Coverage

• 1.1 Cystic Fibrosis Drugs Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Cystic Fibrosis Drugs Market Size Growth Rate by Product
  • 1.4.2 Oral
  • 1.4.3 Injection
• 1.5 Market by End User
  • 1.5.1 Global Cystic Fibrosis Drugs Market Size Growth Rate by End User
  • 1.5.2 Hospitals
  • 1.5.3 Clinics
  • 1.5.4 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Cystic Fibrosis Drugs Market Size
  • 2.1.1 Global Cystic Fibrosis Drugs Revenue 2014-2025
  • 2.1.2 Global Cystic Fibrosis Drugs Sales 2014-2025
• 2.2 Cystic Fibrosis Drugs Growth Rate by Regions
  • 2.2.1 Global Cystic Fibrosis Drugs Sales by Regions
  • 2.2.2 Global Cystic Fibrosis Drugs Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Cystic Fibrosis Drugs Sales by Manufacturers
  • 3.1.1 Cystic Fibrosis Drugs Sales by Manufacturers
  • 3.1.2 Cystic Fibrosis Drugs Sales Market Share by Manufacturers
  • 3.1.3 Global Cystic Fibrosis Drugs Market Concentration Ratio (CR5 and HHI)
• 3.2 Cystic Fibrosis Drugs Revenue by Manufacturers
  • 3.2.1 Cystic Fibrosis Drugs Revenue by Manufacturers (2014-2019)
  • 3.2.2 Cystic Fibrosis Drugs Revenue Share by Manufacturers (2014-2019)
• 3.3 Cystic Fibrosis Drugs Price by Manufacturers
• 3.4 Cystic Fibrosis Drugs Manufacturing Base Distribution, Product Types
  • 3.4.1 Cystic Fibrosis Drugs Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Cystic Fibrosis Drugs Product Type
  • 3.4.3 Date of International Manufacturers Enter into Cystic Fibrosis Drugs Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Cystic Fibrosis Drugs Sales by Product
• 4.2 Global Cystic Fibrosis Drugs Revenue by Product
• 4.3 Cystic Fibrosis Drugs Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Cystic Fibrosis Drugs Breakdown Data by End User

6 North America

• 6.1 North America Cystic Fibrosis Drugs by Countries
  • 6.1.1 North America Cystic Fibrosis Drugs Sales by Countries
  • 6.1.2 North America Cystic Fibrosis Drugs Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Cystic Fibrosis Drugs by Product
• 6.3 North America Cystic Fibrosis Drugs by End User

7 Europe

• 7.1 Europe Cystic Fibrosis Drugs by Countries
  • 7.1.1 Europe Cystic Fibrosis Drugs Sales by Countries
  • 7.1.2 Europe Cystic Fibrosis Drugs Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Cystic Fibrosis Drugs by Product
• 7.3 Europe Cystic Fibrosis Drugs by End User

8 Asia Pacific

• 8.1 Asia Pacific Cystic Fibrosis Drugs by Countries
  • 8.1.1 Asia Pacific Cystic Fibrosis Drugs Sales by Countries
  • 8.1.2 Asia Pacific Cystic Fibrosis Drugs Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Cystic Fibrosis Drugs by Product
• 8.3 Asia Pacific Cystic Fibrosis Drugs by End User

9 Central & South America

• 9.1 Central & South America Cystic Fibrosis Drugs by Countries
  • 9.1.1 Central & South America Cystic Fibrosis Drugs Sales by Countries
  • 9.1.2 Central & South America Cystic Fibrosis Drugs Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Cystic Fibrosis Drugs by Product
• 9.3 Central & South America Cystic Fibrosis Drugs by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Cystic Fibrosis Drugs by Countries
  • 10.1.1 Middle East and Africa Cystic Fibrosis Drugs Sales by Countries
  • 10.1.2 Middle East and Africa Cystic Fibrosis Drugs Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Cystic Fibrosis Drugs by Product
• 10.3 Middle East and Africa Cystic Fibrosis Drugs by End User

11 Company Profiles

• 11.1 Actavis
  • 11.1.1 Actavis Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Actavis Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Actavis Cystic Fibrosis Drugs Products Offered
  • 11.1.5 Actavis Recent Development
• 11.2 F. Hoffmann-La Roche
  • 11.2.1 F. Hoffmann-La Roche Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 F. Hoffmann-La Roche Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 F. Hoffmann-La Roche Cystic Fibrosis Drugs Products Offered
  • 11.2.5 F. Hoffmann-La Roche Recent Development
• 11.3 Gilead Sciences
  • 11.3.1 Gilead Sciences Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Gilead Sciences Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Gilead Sciences Cystic Fibrosis Drugs Products Offered
  • 11.3.5 Gilead Sciences Recent Development
• 11.4 Novartis
  • 11.4.1 Novartis Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Novartis Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Novartis Cystic Fibrosis Drugs Products Offered
  • 11.4.5 Novartis Recent Development
• 11.5 Vertex Pharmaceuticals
  • 11.5.1 Vertex Pharmaceuticals Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Vertex Pharmaceuticals Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Vertex Pharmaceuticals Cystic Fibrosis Drugs Products Offered
  • 11.5.5 Vertex Pharmaceuticals Recent Development
• 11.6 Abbott
  • 11.6.1 Abbott Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Abbott Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Abbott Cystic Fibrosis Drugs Products Offered
  • 11.6.5 Abbott Recent Development
• 11.7 Anthera Pharmaceuticals
  • 11.7.1 Anthera Pharmaceuticals Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Anthera Pharmaceuticals Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Anthera Pharmaceuticals Cystic Fibrosis Drugs Products Offered
  • 11.7.5 Anthera Pharmaceuticals Recent Development
• 11.8 Arcturus Therapeutics
  • 11.8.1 Arcturus Therapeutics Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Arcturus Therapeutics Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Arcturus Therapeutics Cystic Fibrosis Drugs Products Offered
  • 11.8.5 Arcturus Therapeutics Recent Development
• 11.9 Boehringer Ingelheim
  • 11.9.1 Boehringer Ingelheim Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Boehringer Ingelheim Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Boehringer Ingelheim Cystic Fibrosis Drugs Products Offered
  • 11.9.5 Boehringer Ingelheim Recent Development
• 11.10 Chiesi Farmaceutici
  • 11.10.1 Chiesi Farmaceutici Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Chiesi Farmaceutici Cystic Fibrosis Drugs Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Chiesi Farmaceutici Cystic Fibrosis Drugs Products Offered
  • 11.10.5 Chiesi Farmaceutici Recent Development
• 11.11 Corbus Pharmaceuticals
• 11.12 Genzyme
• 11.13 Insmed
• 11.14 Johnson & Johnson
• 11.15 Merck Sharp & Dohme
• 11.16 Neovii Biotech
• 11.17 Novo Nordisk
• 11.18 PharmaSwiss
• 11.19 Pharmaxis
• 11.20 Proteostasis Therapeutics
• 11.21 PTC Therapeutics
• 11.22 United Medical
• 11.23 Venus Remedies

12 Future Forecast

• 12.1 Cystic Fibrosis Drugs Market Forecast by Regions
  • 12.1.1 Global Cystic Fibrosis Drugs Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Cystic Fibrosis Drugs Revenue Forecast by Regions 2019-2025
• 12.2 Cystic Fibrosis Drugs Market Forecast by Product
  • 12.2.1 Global Cystic Fibrosis Drugs Sales Forecast by Product 2019-2025
  • 12.2.2 Global Cystic Fibrosis Drugs Revenue Forecast by Product 2019-2025
• 12.3 Cystic Fibrosis Drugs Market Forecast by End User
• 12.4 North America Cystic Fibrosis Drugs Forecast
• 12.5 Europe Cystic Fibrosis Drugs Forecast
• 12.6 Asia Pacific Cystic Fibrosis Drugs Forecast
• 12.7 Central & South America Cystic Fibrosis Drugs Forecast
• 12.8 Middle East and Africa Cystic Fibrosis Drugs Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Cystic Fibrosis Drugs Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details